An ILC2-chitinase circuit restores lung homeostasis after epithelial injury.


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
18 Oct 2024
Historique:
medline: 18 10 2024
pubmed: 18 10 2024
entrez: 18 10 2024
Statut: ppublish

Résumé

Environmental exposures increase the risk for severe lung disease, but specific drivers of persistent epithelial injury and immune dysfunction remain unclear. Here, we identify a feedback circuit triggered by chitin, a common component of airborne particles, that affects lung health after epithelial injury. In mice, epithelial damage disrupts lung chitinase activity, leading to environmental chitin accumulation, impaired epithelial renewal, and group 2 innate lymphoid cell (ILC2) activation. ILC2s, in turn, restore homeostasis by inducing acidic mammalian chitinase (AMCase) in regenerating epithelial cells and promoting chitin degradation, epithelial differentiation, and inflammatory resolution. Mice lacking AMCase or ILC2s fail to clear chitin and exhibit increased mortality and impaired epithelial regeneration after injury. These effects are ameliorated by chitinase replacement therapy, demonstrating that chitin degradation is crucial for recovery after various forms of lung perturbation. Thus, the ILC2-chitinase response circuit may serve as a target for alleviating persistent postinjury lung epithelial and immune dysfunction.

Identifiants

pubmed: 39423283
doi: 10.1126/sciimmunol.adl2986
doi:

Substances chimiques

Chitinases EC 3.2.1.14
Chitin 1398-61-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadl2986

Auteurs

Haerin Jung (H)

Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Do-Hyun Kim (DH)

Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Roberto Efraín Díaz (RE)

Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.

J Michael White (JM)

Department of Pathology & Immunology, Washington University Gnotobiotic Core Facility, Washington University School of Medicine, St. Louis, MO, USA.

Summer Rucknagel (S)

Department of Pathology & Immunology, Washington University Gnotobiotic Core Facility, Washington University School of Medicine, St. Louis, MO, USA.

Lauryn Mosby (L)

Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Yilin Wang (Y)

Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Sanjana Reddy (S)

Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Emma S Winkler (ES)

Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Ahmed O Hassan (AO)

Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Baoling Ying (B)

Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Michael S Diamond (MS)

Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.
Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, USA.
Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St. Louis, MO, USA.

Richard M Locksley (RM)

Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA.
Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA.

James S Fraser (JS)

Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.

Steven J Van Dyken (SJ)

Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH